Voloridge Investment Management, LLC Biocryst Pharmaceuticals Inc Transaction History

Voloridge Investment Management, LLC

$26.2 Billion
Q3 2024

A detailed history of Voloridge Investment Management, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 1,792,908 shares of BCRX stock, worth $13.6 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,792,908

Previous 2,590,861 30.8%

Holding current value

$13.6 Million

Previous $16 Million 14.9%

% of portfolio

0.05%

Previous 0.06%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$6.41 - $8.69 $5.11 Million - $6.93 Million	-797,953 Reduced 30.8%	1,792,908 $13.6 Million
Q2 2024 Aug 14, 2024	BUY	$4.13 - $6.79 $6.7 Million - $11 Million	1,623,139 Added 167.73%	2,590,861 $16 Million
Q1 2024 May 15, 2024	SELL	$4.89 - $7.65 $557,088 - $871,518	-113,924 Reduced 10.53%	967,722 $4.92 Million
Q4 2023 Feb 14, 2024	BUY	$4.98 - $6.77 $3.67 Million - $4.99 Million	737,798 Added 214.57%	1,081,646 $6.48 Million
Q3 2023 Nov 14, 2023	BUY	$6.71 - $7.92 $1.69 Million - $2 Million	252,451 Added 276.21%	343,848 $2.43 Million
Q2 2023 Aug 14, 2023	SELL	$6.96 - $8.81 $4.05 Million - $5.13 Million	-581,868 Reduced 86.42%	91,397 $643,000
Q1 2023 May 15, 2023	BUY	$7.94 - $11.84 $3.24 Million - $4.83 Million	408,048 Added 153.85%	673,265 $5.62 Million
Q4 2022 Feb 14, 2023	BUY	$10.5 - $14.2 $2.78 Million - $3.77 Million	265,217 New	265,217 $3.04 Million
Q2 2022 Aug 15, 2022	SELL	$7.89 - $17.88 $1.01 Million - $2.28 Million	-127,510 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$11.56 - $19.76 $6.55 Million - $11.2 Million	-566,320 Reduced 81.62%	127,510 $2.07 Million
Q4 2021 Feb 14, 2022	SELL	$11.18 - $15.46 $5.44 Million - $7.52 Million	-486,467 Reduced 41.22%	693,830 $9.61 Million
Q3 2021 Nov 15, 2021	BUY	$14.21 - $17.65 $8.64 Million - $10.7 Million	607,919 Added 106.21%	1,180,297 $17 Million
Q2 2021 Aug 16, 2021	BUY	$9.5 - $17.24 $5.44 Million - $9.87 Million	572,378 New	572,378 $9.05 Million
Q1 2021 May 17, 2021	SELL	$7.37 - $13.61 $7.66 Million - $14.1 Million	-1,038,874 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.37 - $8.61 $3.5 Million - $8.94 Million	1,038,874 New	1,038,874 $7.74 Million
Q4 2019 Feb 14, 2020	SELL	$1.59 - $3.45 $56,677 - $122,978	-35,646 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$2.5 - $3.73 $236,635 - $353,059	-94,654 Reduced 72.64%	35,646 $102,000
Q2 2019 Aug 14, 2019	BUY	$2.91 - $9.15 $342,783 - $1.08 Million	117,795 Added 941.98%	130,300 $494,000
Q1 2019 May 15, 2019	BUY	$7.38 - $9.72 $92,286 - $121,548	12,505 New	12,505 $102,000

Others Institutions Holding BCRX

# of Institutions

279

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account

Voloridge Investment Management, LLC Biocryst Pharmaceuticals Inc Transaction History